Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Designed to Assess the Safety and Effectiveness of the KOKO™ Device In Treating Primary Abnormal Postpartum Uterine Bleeding ("APUB") or Hemorrhage ("PPH")

NCT06452355 is registered in ClinicalTrials.gov with KOKO Medical Inc. as lead sponsor.

NCT NCT06452355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06452355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Designed to Assess the Safety and Effectiveness of the KOKO™ Device In Treating Primary Abnormal Postpartum Uterine Bleeding ("APUB") or Hemorrhage ("PPH")
Lead sponsor
KOKO Medical Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 29, 2024
Completion date
July 29, 2026
Enrollment
73 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, postpartum, immediate postpartum hemorrhage, postpartum hemorrhage